Regulus Therapeutics Announces Timing for Third Quarter 2021 Financial Results Webcast and Conference Call

SAN DIEGO: SAN DIEGO, Nov. 3, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that it will report financial results and highlights for the quarter ended September 30, 2021 on Wednesday, November 10, 2021, after the U.S. financial markets close.
Click here to view original post